Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Fu Tao

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Chemistry & Biology|September 5, 2003
Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamidesToshikazu Bando, Hirokazu Iida, Zhi Fu Tao, et al.
Organic Letters|April 2, 2002
Deglycobleomycin: solid-phase synthesis and DNA cleavage by the resin-bound ligandKenneth L Smith, Zhi-Fu Tao, Shigeki Hashimoto, et al.
Journal of the American Chemical Society|August 21, 2003
Conformationally constrained analogues of bleomycin A5Michael J Rishel, Craig J Thomas, Zhi-Fu Tao, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 1, 2014
Regulation of autophagy by high glucose in human retinal pigment epitheliumJin Yao, Zhi-Fu Tao, Chao-Peng Li, et al.
Journal of the American Chemical Society|October 31, 2002
Solid-phase synthesis of bleomycin A(5) and three monosaccharide analogues: exploring the role of the carbohydrate moiety in RNA cleavageCraig J Thomas, Alexander O Chizhov, Christopher J Leitheiser, et al.
Journal of the American Chemical Society|April 11, 2002
Alteration of the selectivity of DNA cleavage by a deglycobleomycin analogue containing a trithiazole moietyCraig J Thomas, Michael M McCormick, Corine Vialas, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2008
Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitorsZhan Xiao, John Xue, Wen-Zhen Gu, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Macrocyclic ureas as potent and selective Chk1 inhibitors: an improved synthesis, kinome profiling, structure-activity relationships, and preliminary pharmacokineticsZhi-Fu Tao, Zehan Chen, Mai-Ha Bui, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitorsGaoquan Li, Zhi-Fu Tao, Yunsong Tong, et al.
Circulation Research|January 15, 2015
lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNABiao Yan, Jin Yao, Jing-Yu Liu, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Chemistry & Biology|September 5, 2003
Sequence specificity, reactivity, and antitumor activity of DNA-alkylating pyrrole-imidazole diamidesToshikazu Bando, Hirokazu Iida, Zhi Fu Tao, et al.
Organic Letters|April 2, 2002
Deglycobleomycin: solid-phase synthesis and DNA cleavage by the resin-bound ligandKenneth L Smith, Zhi-Fu Tao, Shigeki Hashimoto, et al.
Journal of the American Chemical Society|August 21, 2003
Conformationally constrained analogues of bleomycin A5Michael J Rishel, Craig J Thomas, Zhi-Fu Tao, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 1, 2014
Regulation of autophagy by high glucose in human retinal pigment epitheliumJin Yao, Zhi-Fu Tao, Chao-Peng Li, et al.
Journal of the American Chemical Society|October 31, 2002
Solid-phase synthesis of bleomycin A(5) and three monosaccharide analogues: exploring the role of the carbohydrate moiety in RNA cleavageCraig J Thomas, Alexander O Chizhov, Christopher J Leitheiser, et al.
Journal of the American Chemical Society|April 11, 2002
Alteration of the selectivity of DNA cleavage by a deglycobleomycin analogue containing a trithiazole moietyCraig J Thomas, Michael M McCormick, Corine Vialas, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|August 2, 2008
Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitorsZhan Xiao, John Xue, Wen-Zhen Gu, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Macrocyclic ureas as potent and selective Chk1 inhibitors: an improved synthesis, kinome profiling, structure-activity relationships, and preliminary pharmacokineticsZhi-Fu Tao, Zehan Chen, Mai-Ha Bui, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2007
Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitorsGaoquan Li, Zhi-Fu Tao, Yunsong Tong, et al.
Circulation Research|January 15, 2015
lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNABiao Yan, Jin Yao, Jing-Yu Liu, et al.
Pageof 4